Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 24 January 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 24 January 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that Board of Directors of the company in their meeting held on January 21, 2021 at 2.30 PM decided to enter into a binding commitment with Sanofi Group regarding the acquisition of a majority stake in Sanofi Bangladesh Limited for a base-price consideration of circa Pound 35.5 million, to be adjusted as set out below (the Proposed Transaction). The Proposed Transaction is subject to approval by the Bangladesh Bank and completing the Share Purchase Agreement. (Cont.1)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace8c5a6b00004005492e
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.